Paclitaxel
Who holds supplier records for Paclitaxel? 23 organisations hold a current record for Paclitaxel: an active US FDA Type II Drug Master File or a CEP. A further 27 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability (19 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (5), China (5), South Korea (2), Taiwan (1) and 4 other countries (4); not recorded for 6.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Paclitaxel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/paclitaxel
Reading the evidence
- 23 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Paclitaxel expires 12 Jul 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (23)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Paclitaxel. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 36253, 26792 · latest filing Sept 2021
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 16676, 27567 · latest filing Dec 2014
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 36228 · latest filing Aug 2021
- Chongqing Sintaho Pharmaceutical Co., Ltd.ChinaCEPActive DMF 36479 · latest filing Nov 2021
- CORDEN PHARMA BOULDER INCCEPActive DMF 16439 · latest filing Feb 2003
- Fujian South Pharmaceutical Co. Ltd.ChinaCEPActive DMF 25822, 23558 · latest filing Feb 2012
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 26688 · latest filing Dec 2012
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 32194 · latest filing Oct 2017
- SERIPHARM SASFranceCEPActive DMF 12294 · latest filing Dec 1996
- TAPI NL BVNetherlandsCEPActive DMF 16701 · latest filing Jul 2003
- WUHAN CALMLAND PHARMACEUTICALS CO LTDChinaCEP Company GMP cert on recordActive DMF 32512 · latest filing Jan 2018
- GUILIN HUIANG BIOCHEMISTRY PHARMACEUTICAL CO LTDActive DMF 17045 · latest filing Dec 2003
- HAINAN YEW PHARMACEUTICAL CO LTDActive DMF 27049 · latest filing Apr 2013
- SAMYANG HOLDINGS CORPSouth KoreaActive DMF 14338 · latest filing Aug 1999
- YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDActive DMF 15319 · latest filing Feb 2001
- YUNNAN HANDE BIO-TECH CO LTDChinaActive DMF 11909 · latest filing Mar 1996
- IndiaCEP Company GMP cert on record
- INDENA SPAItalyCEP Company GMP cert on recordInactive DMF 12876 · latest filing Feb 1998
- ChinaCEP Company GMP cert on record
- POLYMED THERAPEUTICS INCCEPInactive DMF 18397, 27900 · latest filing Jan 2014
- South KoreaCEP
- WUXI TAXUS PHARMACEUTICAL CO LTDCEP
- PHYTON BIOTECH LLCCanadaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (19)
Certificates of Suitability on the EDQM register for Paclitaxel, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 34 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2009-236 - Rev 07 Paclitaxel, Produced by semi-synthetic process | Sept 2026 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2021-455 - Rev 01 Paclitaxel, Produced by a semi-synthetic process – Process II | Jul 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2021-476 - Rev 01 Paclitaxel, Produced by a semi-synthetic process | May 2026 | — |
| SAMYANG BIOPHARM CORP. Seongnam-Si | KR | CEP 2009-255 - Rev 03 Paclitaxel, Produced by fermentation | Apr 2026 | — |
| SCINOPHARM TAIWAN LTD. Tainan | TW | CEP 2015-278 - Rev 02 Paclitaxel, Produced by a semi-synthetic process, product code SPT 1308 | Mar 2026 | — |
| WUXI TAXUS PHARMACEUTICAL CO. LTD. Wuxi City | CN | CEP 2024-437 - Rev 00 Paclitaxel | Nov 2025 | — |
| CHONGQING SINTAHO PHARMACEUTICAL CO., LTD. Maliuzui | CN | CEP 2022-006 - Rev 01 Paclitaxel, Produced by a semi-synthetic process | Oct 2025 | — |
| FRESENIUS KABI ONCOLOGY LIMITED Kalyani | IN | CEP 2008-181 - Rev 12 Paclitaxel, Semi-synthetic process | Sept 2025 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | CEP 2020-038 - Rev 02 Paclitaxel, Produced by a semi-synthetic process | Aug 2025 | Inspected Aug 2026 Slovakia |
| PHYTON BIOTECH LLC Delta | CA | CEP 2024-022 - Rev 01 Paclitaxel, Produced by fermentation - Site Agno | Jul 2025 | — |
| FUJIAN SOUTH PHARMACEUTICAL CO., LTD. Sanming | CN | CEP 2019-110 - Rev 03 Paclitaxel, Produced by a semi-synthetic process | Jun 2025 | — |
| INDENA S.P.A. Milan | IT | CEP 2019-346 - Rev 06 Paclitaxel, Produced by a semi-synthetic process – Process II | Feb 2025 | Inspected Jun 2026 Italy |
| Ningbo Green-Health Pharmaceutical Co., Ltd. Ningbo | CN | CEP 2022-267 - Rev 00 Paclitaxel, produced by a semi-synthetic process | Oct 2024 | Inspected Jun 2024 Germany |
| WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan | CN | CEP 2018-004 - Rev 02 Paclitaxel, produced by a semi-synthetic process | May 2024 | Inspected Apr 2026 Croatia |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2021-122 - Rev 02 Paclitaxel, Produced by a semi-synthetic process | Dec 2023 | — |
| INDENA S.P.A. Milano | IT | R1-CEP 2008-102 - Rev 03 Paclitaxel, produced by semi-synthetic process | Oct 2022 | — |
| POLYMED THERAPEUTICS, INC. Houston | US | R1-CEP 2014-192 - Rev 00 Paclitaxel, Produced by a semi-synthetic process | Jun 2021 | — |
| CORDEN PHARMA BOULDER, INC. Boulder | US | R1-CEP 2009-126 - Rev 01 Paclitaxel, Produced by a semi-synthetic process | Feb 2021 | — |
| SERIPHARM S.A.S. Le Mans | FR | R1-CEP 2008-327 - Rev 00 Paclitaxel, Produced by a semi-synthetic process | Sept 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (27)
Organisations whose Type II DMFs for Paclitaxel are no longer active. These show a past filing, not current supply.
Show all 27 historical records
- India · Inactive DMF 25870 · filed Mar 2012
- MAC CHEM PRODUCTS INDIA PVT LTDInactive DMF 25843 · filed Mar 2012
- JIANGSU YEW PHARMACEUTICAL CO LTDInactive DMF 25759 · filed Jan 2012
- SAI PHYTOCEUTICALS PVT LTDInactive DMF 19660 · filed Jul 2006
- BEIJING YI HE BIOTECH CO LTDInactive DMF 19421 · filed May 2006
- SHANGHAI JINSHAN BIOTECH CO LTDInactive DMF 19293 · filed Mar 2006
- CHONGQING UNITED PHARMACEUTICAL CO LTDInactive DMF 19159, 16891 · filed Jan 2006
- YUNNAN ZIYUN BIO TECH CO LTDInactive DMF 17965 · filed Jan 2005
- Inactive DMF 17650 · filed Sept 2004
- PAXIS PHARMACEUTICALSInactive DMF 17457 · filed Jun 2004
- XIAN HIGH TECH INDUSTRIES CO LTDInactive DMF 15961 · filed Apr 2002
- TAIHUA NATURAL PLANT PHARMACEUTICAL CO LTDInactive DMF 15382 · filed Apr 2001
- SOUTHERN HERBALS LTDInactive DMF 15200 · filed Nov 2000
- HOSPIRA BOULDER INCInactive DMF 15092 · filed Oct 2000
- BIOXEL PHARMA INCInactive DMF 14503 · filed Oct 1999
- LD PHARMACEUTICALInactive DMF 14403 · filed Sept 1999
- CHROMADEX INCInactive DMF 14389 · filed Aug 1999
- NAPRO BIOTHERAPEUTICS INCInactive DMF 10504, 14350, 11841 · filed Aug 1999
- KUNMING INSTITUTE OF BOTANYInactive DMF 13980 · filed Feb 1999
- HUIANG BIO CHEMICAL PRODUCT MANUFACTURE COMPANY LTDInactive DMF 13826 · filed Nov 1998
- CHONGQING UNIT MODERN TECHNOLOGY CO LTDInactive DMF 13148 · filed Aug 1998
- CSF BIOTECHInactive DMF 13016 · filed Jun 1998
- INDENA UK LTDInactive DMF 12757 · filed Nov 1997
- XECHEM INCInactive DMF 12544 · filed Jun 1997
- PHYTOGEN LIFE SCIENCES INCInactive DMF 12130 · filed Aug 1996
- GREEN SPRINGS BIOCHEMISTRYInactive DMF 12069 · filed Jul 1996
- HAUSER CHEMICAL RESEARCH INCInactive DMF 9765, 8801, 11248 · filed Sept 1995
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (16 listed products contain Paclitaxel). The latest listed patent expires 12 Jul 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Paclitaxel is a chemotherapy drug used to treat various types of cancer, including ovarian, breast, and non-small cell lung cancer. It works by interfering with the normal function of microtubules during cell division.
Chemical identity
- IUPAC name
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- Canonical SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
- InChIKey
- RCINICONZNJXQF-MZXODVADSA-N
- Synonyms
- Taxol, (-)-paclitaxel, abi 007 component paclitaxel, abi-007 component paclitaxel, abraxane component paclitaxel, bms-181339-01, capxol, cyclopax, dhp-107, ebetaxel, empac, endotag 1
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Microtubule Inhibitor
- Physiologic effect
- Microtubule Inhibition
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Paclitaxel?
23 organisations hold an active US FDA Type II Drug Master File or a CEP for Paclitaxel: Intas Pharmaceuticals Ltd. (India), SCINOPHARM TAIWAN LTD (Taiwan), APITORIA PHARMA PRIVATE LTD (India), Chongqing Sintaho Pharmaceutical Co., Ltd. (China), CORDEN PHARMA BOULDER INC, Fujian South Pharmaceutical Co. Ltd. (China), Hetero Labs Limited (India) and MSN Laboratories Private Limited (India), and 15 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Paclitaxel Drug Master Files are active?
Intas Pharmaceuticals Ltd. (DMF 36253, 26792), SCINOPHARM TAIWAN LTD (DMF 16676, 27567), APITORIA PHARMA PRIVATE LTD (DMF 36228), Chongqing Sintaho Pharmaceutical Co., Ltd. (DMF 36479), CORDEN PHARMA BOULDER INC (DMF 16439), Fujian South Pharmaceutical Co. Ltd. (DMF 25822, 23558), Hetero Labs Limited (DMF 26688) and MSN Laboratories Private Limited (DMF 32194) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Paclitaxel records mean?
27 organisations have only inactive Type II DMFs for Paclitaxel. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Paclitaxel have a European Certificate of Suitability?
Yes. 18 organisations hold a valid CEP for Paclitaxel on the EDQM register, including TAPI NL B.V. Amsterdam (NL), INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN), HETERO LABS LIMITED Hyderabad (IN), SAMYANG BIOPHARM CORP. Seongnam-Si (KR), SCINOPHARM TAIWAN LTD. Tainan (TW) and WUXI TAXUS PHARMACEUTICAL CO. LTD. Wuxi City (CN) and 13 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Paclitaxel?
Yes. The latest patent listed for an approved US product containing Paclitaxel expires 12 Jul 2034, across 16 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Paclitaxel supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Paclitaxel?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.